Your weekly roundup of the latest news from Drug Topics®.
A recent study examined the effects that different work environments can have on adults with asthma.
Hesitation from patients and providers to switch to an infliximab biosimilar may not be necessary, new study finds.
According to Dermavant, tapinarof cream 1% is a novel, aryl hydrocarbon receptor agonist in development as a once-daily topical cream.
G2Retro, developed by investigators from Ohio State University, can produce hundreds of new reaction predictions in just a few minutes.
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.